In the BioHarmony Drug Report Database

"Preview" Icon

Tranexamic acid

Cyklokapron, Lysteda, Tranexamic Acid (tranexamic acid) is a small molecule pharmaceutical. Tranexamic acid was first approved as Cyklokapron on 1986-12-30. It is used to treat inherited blood coagulation disorders and subarachnoid hemorrhage in the USA. The pharmaceutical is active against plasminogen. Cyklokapron’s patent is valid until 2025-03-04 (FDA).

 

Trade Name

 

Cyklokapron, Lysteda, Tranexamic Acid
 

Common Name

 

tranexamic acid
 

ChEMBL ID

 

CHEMBL877
 

Indication

 

inherited blood coagulation disorders, subarachnoid hemorrhage
 

Drug Class

 

Image (chem structure or protein)

Tranexamic acid structure rendering